Cannabis as Medicine

Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

Key Points Question:  What are the risks and benefits of obtaining a medical marijuana card for adults who seek medical marijuana for pain, insomnia, and anxiety or depressive symptoms? Findings: In this randomized clinical trial involving 186 participants, immediate acquisition of a medical marijuana card increased the incidence and severity of cannabis use disorder (CUD) and resulted

Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial Read More »

Using Cannabis Whilst Pregnant Messes with the Baby’s Immune Gene Networks & Predisposes the Child to Anxiety.

(Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring) PNAS November 23,2021; https://doi.org/10.1073/pnas.2106115118 Significance: Cannabis use is becoming more prevalent, including during developmentally sensitive periods such as pregnancy. Here we find that maternal cannabis use is associated with increased cortisol, anxiety, aggression, and hyperactivity in young children.

Using Cannabis Whilst Pregnant Messes with the Baby’s Immune Gene Networks & Predisposes the Child to Anxiety. Read More »

Weed for ‘Morning Sickness’ is a Bad Option of Many Levels!

CONCLUSIONS AND RELEVANCE: Considerable growth was observed in the prevalence of CUD diagnoses among individuals hospitalized prenatally and in the prevalence of depression, anxiety, nausea, and other conditions in individuals with CUD at hospitalization. This study  highlights the need for more screening, prevention, and treatment, particularly in populations with co-occurring CUD and psychiatric disorders. Research

Weed for ‘Morning Sickness’ is a Bad Option of Many Levels! Read More »

‘Another level’: Race on to get over-the-counter cannabis meds to pharmacies

By Emma Koehn September 2021 ASX-listed cannabis companies are racing to get low-dose medicinal pot products onto shelves, with hopes they will be available through pharmacies by the end of next year. In February, the country’s medicines regulator – the Therapeutic Goods Administration (TGA) – agreed to change the classification for certain products containing small amounts

‘Another level’: Race on to get over-the-counter cannabis meds to pharmacies Read More »

Planting the seed for marijuana use: Changes in exposure to medical marijuana advertising and subsequent adolescent marijuana use, cognitions, and consequences over seven years

Results: Higher average exposure to MM advertising was associated with higher average use, intentions to use, positive expectancies, and negative consequences. Similarly, higher rates of change in MM advertising exposure were associated with higher rates of change in use, intentions, expectancies, and consequences over seven years. Conclusions: Results suggest that exposure to MM advertising may

Planting the seed for marijuana use: Changes in exposure to medical marijuana advertising and subsequent adolescent marijuana use, cognitions, and consequences over seven years Read More »

Pain response to cannabidiol (CBD) in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial

Abstract Preclinical studies have demonstrated the analgesic potential of cannabidiol (CBD). Those suggesting an effect on pain-processing receptors have brought CBD back into focus. This study assessed the effect of CBD on acute pain, hyperalgesia, and allodynia compared with placebo. Twenty healthy volunteers were included in this randomized, placebo-controlled, double-blinded, crossover study assessing pain intensities

Pain response to cannabidiol (CBD) in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial Read More »

Scroll to Top